The Roles of NOTCH3 p.R544C and Thrombophilia Genes in Vietnamese Patients With Ischemic Stroke: Study Involving a Hierarchical Cluster Analysis
Open Access
- 7 May 2024
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Bioinformatics and Biotechnology
- Vol. 5 (1) , e56884
Abstract
Background: The etiology of ischemic stroke is multifactorial. Several gene mutations have been identified as leading causes of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a hereditary disease that causes stroke and other neurological symptoms. Objective: We aimed to identify the variants of NOTCH3 and thrombophilia genes, and their complex interactions with other factors. Methods: We conducted a hierarchical cluster analysis (HCA) on the data of 100 patients diagnosed with ischemic stroke. The variants of NOTCH3 and thrombophilia genes were identified by polymerase chain reaction with confronting 2-pair primers and real-time polymerase chain reaction. The overall preclinical characteristics, cumulative cutpoint values, and factors associated with these somatic mutations were analyzed in unidimensional and multidimensional scaling models. Results: We identified the following optimal cutpoints: creatinine, 83.67 (SD 9.19) µmol/L; age, 54 (SD 5) years; prothrombin (PT) time, 13.25 (SD 0.17) seconds; and international normalized ratio (INR), 1.02 (SD 0.03). Using the Nagelkerke method, cutpoint 50% values of the Glasgow Coma Scale score; modified Rankin scale score; and National Institutes of Health Stroke Scale scores at admission, after 24 hours, and at discharge were 12.77, 2.86 (SD 1.21), 9.83 (SD 2.85), 7.29 (SD 2.04), and 6.85 (SD 2.90), respectively. Conclusions: The variants of MTHFR (C677T and A1298C) and NOTCH3 p.R544C may influence the stroke severity under specific conditions of PT, creatinine, INR, and BMI, with risk ratios of 4.8 (95% CI 1.53-15.04) and 3.13 (95% CI 1.60-6.11), respectively (Pfisher<.05). It is interesting that although there are many genes linked to increased atrial fibrillation risk, not all of them are associated with ischemic stroke risk. With the detection of stroke risk loci, more information can be gained on their impacts and interconnections, especially in young patients.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Current State of Stroke Care in VietnamStroke: Vascular and Interventional Neurology, 2022
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Neurology, 2021
- Cerebral small vessel disease genomics and its implications across the lifespanNature Communications, 2020
- Correlation and association analyses in microbiome study integrating multiomics in health and disease2020
- Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene “Mutation” (G20210A)Seminars in Thrombosis and Hemostasis, 2019
- Prevalence and clinical characteristics of stroke patients with p.R544C NOTCH3 mutation in TaiwanAnnals of Clinical and Translational Neurology, 2018
- A stroke gene panel for whole-exome sequencingEuropean Journal of Human Genetics, 2018
- Notch3ECD immunotherapy improves cerebrovascular responses in CADASIL miceAnnals of Neurology, 2018
- Coagulation Testing in the Core LaboratoryLaboratory Medicine, 2017
- Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic strokeNature Genetics, 2012